Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
Top Cited Papers
- 11 January 2013
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 339 (6116) , 166-172
Abstract
A number of widespread and devastating chronic diseases, including atherosclerosis, type 2 diabetes, and Alzheimer’s disease, have a pathophysiologically important inflammatory component. In these diseases, the precise identity of the inflammatory stimulus is often unknown and, if known, is difficult to remove. Thus, there is interest in therapeutically targeting the inflammatory response. Although there has been success with anti-inflammatory therapy in chronic diseases triggered by primary inflammation dysregulation or autoimmunity, there are considerable limitations. In particular, the inflammatory response is critical for survival. As a result, redundancy, compensatory pathways, and necessity narrow the risk:benefit ratio of anti-inflammatory drugs. However, new advances in understanding inflammatory signaling and its links to resolution pathways, together with new drug development, offer promise in this area of translational biomedical research.Keywords
This publication has 71 references indexed in Scilit:
- PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cellsNature, 2012
- Insulin Resistance, Hyperglycemia, and AtherosclerosisCell Metabolism, 2011
- Multimodal Clinical Imaging To Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental AtherosclerosisMolecular Pharmaceutics, 2010
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5Nature, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Nonresolving InflammationCell, 2010
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsisNature, 2009
- Jmjd3 contributes to the control of gene expression in LPS‐activated macrophagesThe EMBO Journal, 2009
- Control of Inducible Gene Expression by Signal-Dependent Transcriptional ElongationCell, 2009
- Macrophage-specific PPARγ controls alternative activation and improves insulin resistanceNature, 2007